Intersect Capital’s AstraZeneca AZN Stock Holding History

Intersect Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$321K	Buy	2,426 +98	+4%	+$12.9K	0.1%	219
2022 Q1	$309K	Buy	2,328 +611	+36%	+$73.3K	0.06%	312
2021 Q4	$200K	Sell	1,717 -200	-10%	-$23.5K	0.04%	409
2021 Q3	$230K	Buy	+1,917	New	+$223K	0.04%	344
2015 Q2	–	Sell	-140	Closed	-$10K	–	132
2015 Q1	$10K	Hold	140	–	–	0.01%	327
2014 Q4	$10K	Buy	+140	New	+$10K	0.01%	343

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Intersect Capital's AZN Position: Q2 2022 in Review

Intersect Capital increased its AstraZeneca (AZN) stake by 4.2% in Q2 2022, buying an estimated $12.9K and bringing the position to 2,426 shares worth $321K. The position accounts for 0.1% of the portfolio, ranked #219.

Intersect Capital first reported a position in AZN in Q4 2014 and has held it in 6 quarters since. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

Intersect Capital held 2,426 shares of AstraZeneca worth $321K as of Q2 2022.
Intersect Capital bought 98 AstraZeneca shares in Q2 2022, an estimated $12.9K.
AstraZeneca made up 0.1% of Intersect Capital's portfolio in Q2 2022, its #219 holding.
Intersect Capital first reported a position in AstraZeneca in Q4 2014 and has held it in 6 quarters since.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.